Nephrology

Papers
(The median citation count of Nephrology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Update on diagnosis, pathophysiology, and management of diabetic kidney disease64
Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF‐PH inhibitors56
Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time36
Shear wave elastography accurately detects chronic changes in renal histopathology29
Urinary exosomes: Potential biomarkers for diabetic nephropathy28
Evidence‐based medicine—When observational studies are better than randomized controlled trials26
Early predictors of acute kidney injury in COVID‐19 patients26
Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)25
Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances24
Impact of COVID‐19 on maintenance haemodialysis patients: The Indian scenario23
Mediterranean diet and the risk of chronic kidney disease: A systematic review and meta‐analysis22
Posters19
Humoral and cellular immune response to severe acute respiratory syndrome coronavirus‐2 vaccination in haemodialysis and kidney transplant patients18
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE16
Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1‐S COVID‐19 vaccination: A case series of two patients16
Understanding the opposite effects of sex hormones in mediating renal injury15
Consequences of the first and secondCOVID‐19 wave on kidney transplant recipients at a large Indian transplant centre15
Differential expression analysis of urinary exosomal circular RNAs in patients with IgA nephropathy15
Dietary patterns and chronic kidney disease outcomes: A systematic review15
Gross haematuria after mRNA COVID‐19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy14
Effects of transient acute kidney injury, persistent acute kidney injury and acute kidney disease on the long‐term renal prognosis after an initial acute kidney injury event14
Two decades of chronic kidney disease of unknown aetiology (CKDu) research: Existing evidence and persistent gaps from epidemiological studies in Sri Lanka14
Report of two cases of minimal change disease following vaccination for COVID ‐1913
A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial13
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact13
Influence of end stage renal disease on CD28 expression and T‐cell immunity13
Methamphetamine intoxication and acute kidney injury: A prospective observational case series13
Nodakenin alleviates renal ischaemia‐reperfusion injury via inhibiting reactive oxygen species‐induced NLRP3 inflammasome activation12
Posters12
Sodium‐glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence12
A working partnership: A review of shared decision‐making in nephrology12
Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID‐19 in Mexico12
Associations between nephrolithiasis and diabetes mellitus, hypertension and gallstones: A meta‐analysis of cohort studies12
Glomerular hyperfiltration in morbid obesity: Role of the inflammasome signalling12
Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta‐analysis12
Advances in understanding the role of adiponectin in renal fibrosis11
Sodium‐glucose cotransporter‐2 inhibitors and non‐steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin‐angiotensin system blockade11
Renal supportive care, palliative care and end‐of‐life care: Perceptions of similarities, differences and challenges across Australia and New Zealand11
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease – An Executive Summary11
The case for increased peritoneal dialysis utilization in low‐ and lower‐middle‐income countries11
The COVID‐19 pandemic and access to health care in people with chronic kidney disease: A systematic review and meta‐analysis11
Gut microbiota, key to unlocking the door of diabetic kidney disease11
Funnel plots of patient‐reported outcomes to evaluate health‐care quality: Basic principles, pitfalls and considerations11
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates10
De novo and relapsing glomerulonephritis after COVID‐19 vaccination: how much do we know?10
Demographics and long‐term outcomes of children with end‐stage kidney disease: A 20‐year territory‐wide study10
Systemic complement activation in anti‐neutrophil cytoplasmic antibody‐associated vasculitis and necrotizing glomerulonephritis10
Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease10
Personalized immunosuppression after kidney transplantation9
The burden of chronic kidney disease in Asia, 1990–2019: Examination of estimates from global burden of disease 2019 study9
Be careful with ecological associations9
Nicotiflorin attenuates cell apoptosis in renal ischemia‐reperfusion injury through activating transcription factor 39
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors9
Acute kidney injury associated with COVID‐19—Cumulative evidence and rationale supporting against direct kidney injury (infection)8
A novel urine cell‐free DNA preservation solution and its application in kidney transplantation8
Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006–20208
MiR‐1297 attenuates high glucose‐induced injury in HK‐2 cells via targeting COL1A28
Peritoneal dialysis: Status report in South and South East Asia8
Diastolic and systolic left ventricular dysfunction and mortality in chronic kidney disease patients on haemodialysis7
Dietary interventions on the prevention and management of diabetes in post‐kidney transplantation – A systematic review7
Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease7
Aetiology, practice patterns and burden of end‐stage kidney disease in South Asia and South‐East Asia: A questionnaire‐based survey7
End stage renal disease has an early and continuous detrimental effect on regulatory T cells7
Acute kidney injury in COVID‐19: Identification of risk factors and potential biomarkers of disease in a large UK cohort7
Cardiorespiratory fitness assessed by cardiopulmonary exercise testing between different stages of pre‐dialysis chronic kidney disease: A systematic review and meta‐analysis7
Predictors of technique failure and mortality on peritoneal dialysis: An analysis of New Zealand peritoneal dialysis registry data7
Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy7
Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems7
Perspectives on blood pressure by patients on haemo‐ and peritoneal dialysis7
Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing7
Levofloxacin based non‐rifampicin anti‐tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting7
Case of “relapsing” COVID‐19 in a kidney transplant recipient7
Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients7
Determinants of volume status in peritoneal dialysis: A longitudinal study6
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry6
Changing landscape of dialysis withdrawal in patients with kidney failure: Implications for clinical practice6
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines6
Significant association of urinary alpha‐1‐microglobulin compared to urinary neutrophil gelatinase‐associated lipocalin with renal insufficiency in patients with type 2 diabetes6
Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort6
Mycobacterium tuberculosis peritonitis in peritoneal dialysis patients: A scoping review6
Reducingnon‐melanomaskin cancer risk in renal transplant recipients6
The kinetic estimated glomerular filtration rate ratio predicts acute kidney injury6
Rituximab in maintaining remission in adults with podocytopathy6
Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy6
Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study6
Anxiety and psychosocial impact during coronavirus disease 2019 in home dialysis patients6
Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand6
Qualitative research methods and its application in nephrology6
Immunoglobulin A nephropathy in paediatrics: An up‐to‐date6
Recent research progress on the role of ulinastatin in chronic kidney disease6
Poster Presentations6
Comparison of hospitalization outcomes for delivery and resource utilization between pregnant women with kidney transplants and chronic kidney disease in the United States5
Clinical course of Immunoglobulin A nephropathy with crescents in a multi‐ethnic Southeast Asian cohort5
Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT‐2) trials5
Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf25
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE – EXECUTIVE SUMMARY5
Active deprescribing program in chronic kidney disease patients undergoing haemodialysis5
Association between self‐reported appetite and clinical outcomes of peritoneal dialysis patients: Findings from a low middle‐income country5
Lightning Talks5
Severe hypocalcaemia following denosumab and iron infusion5
Poster Presentations5
Exit site infection and peritonitis due to Serratia species in patients receiving peritoneal dialysis: Epidemiology and clinical outcomes5
Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine5
Exploring rural and remote patients' experiences of health services for kidney disease in Aotearoa New Zealand: An in‐depth interview study5
Clinical factors associated with early and persistent hypocalcaemia after parathyroidectomy in patients on dialysis with severe hyperparathyroidism5
Traditional medicines prescribed for prevention of COVID‐19: Use with caution5
Impact of pre‐transplant biopsy on 5‐year outcomes of expanded criteria donor kidney transplantation5
Impact of imatinib treatment on renal function in chronic myeloid leukaemia patients5
The use of virtual physician mentoring to enhance home dialysis knowledge and uptake5
The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort4
Performance of a pre‐procedural Mehran score to predict acute kidney injury after percutaneous coronary intervention4
The prevalence of chronic kidney disease in Samoans living in Auckland, New Zealand4
Impact of etelcalcetide on fibroblast growth factor‐23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis4
Muscle power and physical dysfunction: A model for tailoring rehabilitation in chronic kidney disease4
Clinical benefits of Tocilizumab in COVID‐19‐related cytokine release syndrome in a patient with end‐stage kidney disease on haemodialysis in Australia4
Protective effect of small extracellular vesicles (EVs) derived from ACE2‐modified human umbilical cord mesenchymal stem cells against renal ischemia–reperfusion injury4
Incremental peritoneal dialysis is a safe and feasible prescription in incident patients with preserved residual kidney function4
Effect of remote patient management in peritoneal dialysis on haemodynamic and volume control4
Histological diagnosis from kidney transplant biopsy can contribute to prediction of graft survival4
Hepatitis B related dilemmas in the renal unit4
Safety and efficacy of Oxford vaccine in kidney transplant recipients: A single‐center prospective analysis from India4
Regional variance in the use of urine dipstick test for outpatients in Japan4
Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns4
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline4
Association of left ventricular hypertrophy and functional impairment with cardiovascular outcomes and mortality among patients with chronic kidney disease, results from the C‐STRIDE study4
Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?4
Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene4
The effect of prescribing vitamin D analogues and serum vitamin D status on both contracting COVID‐19 and clinical outcomes in kidney dialysis patients'4
Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants4
Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis4
The impact of age on patient tolerance of mycophenolate following kidney transplantation4
Misclassification of calcium status in end‐stage kidney disease using albumin‐adjusted calcium levels4
Magnetic resonance imaging determination of tissue sodium in patients with chronic kidney disease4
COVID‐19 vaccine acceptance among patients with glomerulonephritis4
Role of lncRNA‐MEG8/miR‐296‐3p axis in gestational diabetes mellitus4
Spiritual well‐being and its relationship with patient characteristics and other patient‐reported outcomes in peritoneal dialysis patients: Findings from the PDOPPS4
Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients4
The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study3
Systematic review and meta‐analysis of potential pleiotropic effects of sevelamer in chronic kidney disease: Beyond phosphate control3
High prevalence of Afro‐Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalized with COVID‐193
Impact of a kidney‐specific disease‐specific care certification program on the institutional performance indicators of hospitals caring for patients with chronic kidney disease: A national data analys3
The need for individualizing teaching and assurance of knowledge transmission to patients training for home dialysis3
Potential determinants of the E/e′ ratio in non‐dialysis compared with dialysis patients3
From MIA to FIFA: The vicious matrix of frailty, inflammation, fluid overload and atherosclerosis in peritoneal dialysis3
Metformin prevents hypoxia‐induced podocyte injury by regulating the ZEB2/TG2 axis3
New‐onset immunoglobulin‐A nephropathy post severe acute respiratory syndrome‐coronavirus‐2 infection indicates rapidly progressive glomerulonephritis3
Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta‐analysis3
Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF‐κB signalling pathway3
The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease3
Implementation of artificial intelligence Chatbot in peritoneal dialysis nursing care: Experience from a Taiwan medical center3
Posters3
Prognostic significance of carotid plaque presence in peritoneal dialysis patients and its association with the apolipoprotein B/apolipoprotein A1 ratio3
Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease3
Gender and socioeconomic disparities in global burden of chronic kidney disease due to glomerulonephritis: A global analysis3
Prospective model for predicting renal recovery in cardiac surgery patients with acute kidney injury requiring renal replacement therapy3
Profile of urinary exosomal microRNAs and their contribution to diabetic kidney disease through a predictive classification model3
Associations of coenzyme Q10 with endothelial function in hemodialysis patients3
Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease3
Development of a novel AlphaLISA ImmunoAssay for Big angiotensin‐253
Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway3
Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice3
Stroke incidence and chronic kidney disease: A hospital‐based prospective cohort study3
3
Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: A national cohort study3
COVID‐19 death and kidney disease in a multiracial Asian country3
An outpatient model of care for COVID‐19 infected kidney transplant patients – The hospital‐at‐home3
Financial toxicity experienced by rural Australian families with chronic kidney disease3
Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization3
Renal graft artery thrombosis following COVID‐19 infection3
Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic?3
Genetic insight into primary glomerulonephritis3
A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea‐190H) to a standard high flux polysulfone dialyser membrane (2
Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort2
Two novel variants in a Bardet‐Biedl syndrome type 5 patient with severe renal phenotype2
Going to war on COVID‐19: Mobilizing an academic nephrology group practice2
Effect of creatinine metrics on outcome after transplantation of marginal donor kidneys2
Novel gain‐of‐function mutation of TRPC6 Q134P contributes to late onset focal segmental glomerulosclerosis in a Chinese pedigree2
The successful use of rituximab in crescentic IgA nephropathy with concurrent ANCA positivity2
Self‐assessment sheet submission rate predicts technique survival in patients initiating peritoneal dialysis2
Pregnancy and kidney disease: It is time for the birth of prospective registries2
Patient perception of vitality and measured physical activity in patients receiving haemodialysis2
Absent erythropoietin response to anaemia with mild to moderate chronic kidney disease in pregnancy2
Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study2
Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure2
Synbiotic supplement for treatment of iron deficiency anaemia in haemodialysis patients: A randomized controlled trial2
Association between conscientiousness and peritoneal dialysis‐related peritonitis2
Chronic kidney disease in public renal practices in Queensland, Australia, 2011–20182
Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis2
Dialysis initiation in older persons across centres and over time in Australia and New Zealand2
Complementary actions of finerenone and SGLT2‐i on renal outcomes?: An urgent need for more information2
2
Urinary liver‐type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone‐induced acute kidney injury2
The Omicron COVID‐19 threat to dialysis patients is dramatically lower than previous variants2
Belatacept in the treatment of acute T‐cell mediated rejection and maintenance immunosuppression in a paediatric kidney transplant recipient2
Inpatient and outpatient nephrology management of critically ill patients with acute kidney injury2
Changes in renal function and predictors affecting renal outcome of living kidney donors: a nationwide prospective cohort study2
N‐acetyl‐b‐D‐glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality2
Combined effect of obesity and metabolic profile on glomerular dysfunction in hypertensive subjects2
Effects of phosphate binders on bone biomarkers and bone density in haemodialysis patients2
Forkhead box A2‐mediated lncRNA SOX2OT up‐regulation alleviates oxidative stress and apoptosis of renal tubular epithelial cells by promoting SIRT1 expression in diabetic nephrop2
The impact of anatomical variables on haemodialysis tunnelled catheter replacement without fluoroscopy2
A medication frequency error resulting in hypermagnesemia in a patient with kidney failure2
Are individual analyses of multiple short urine collections throughout the 24 hours superior to a standard 24‐hour urine collection in precipitation risk assessment of healthy subjects?2
CircHOMER1 aggravates oxidative stress, inflammation and extracellular matrix deposition in high glucose‐induced human mesangial cells2
Perspectives of a proposed patient navigator programme for people with chronic kidney disease in rural communities: Report from national workshops2
Takayasu's arteritis in a girl with steroid‐dependent nephrotic syndrome: Could rituximab be the culprit?2
COVID‐19 pandemic in limited‐resource countries: Strategies for challenges in a dialysis unit2
Rituximab in treatment of collapsing FSGS—A case series2
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial2
Urinary liver‐type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone2
A case of severe lactic acidosis in a maintenance haemodialysis patient caused by thiamine deficiency: A case report2
Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation2
Digital health technologies to support medication adherence in chronic kidney disease2
Optimal flow volume measurements in forearm versus arm arteriovenous fistulas2
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference2
Renal involvement in monogenic autoinflammatory diseases: A narrative review2
Frequency and risk factors for cognitive dysfunction in peritoneal dialysis patients2
Mean of creatinine clearance and urea clearance examined over 1 h estimates glomerular filtration rate accurately and precisely in children2
A new approach to de novo minimal change disease in pregnancy2
Treatment of chronic active T cell‐mediated rejection after kidney transplantation: A retrospective cohort study of 37 transplants2
Mini Orals2
Cytomegalovirus tubulo‐glomerulitis and intratubular granuloma: Key histopathological findings in allograft cytomegalovirus infection2
Acute kidney injury referred to the nephrologist: A single centre experience in a tertiary care hospital2
Association of central arterial blood pressure and left ventricular hypertrophy in patients with chronic kidney disease1
Crescentic glomerulonephritis induced by anti‐vascular endothelial growth factor receptor 2 antibody1
Mini Orals1
Campylobacter jejuni cyst infection in autosomal dominant polycystic kidney disease1
The prognostic value of CHA2DS2‐VASc and modified‐CHADS2 scores for cardiovascular events in diabetics and non‐diabetics haemodialysis patients1
Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications1
Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease1
Looking beyond catheter removal in polymicrobial peritonitis from unusual enteric bugs1
Safety and utility of kidney biopsy in patients with estimated glomerular filtration rate < 30 ml/min/1.73 m21
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer1
Gemcitabine‐induced renal thrombotic microangiopathy1
Healthcare policy for COVID‐19 patients on haemodialysis: Adapting to the changing needs of the Omicron variant1
Administration route governs the complication: A case report of anaphylaxis due to intravenous erythropoiesis‐stimulating agent1
Any symptom, in any organ, at any age: A case report of multiple genetic diagnoses mimicking mitochondrial disease in an adult with kidney disease1
Abstract Reviewers1
Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome – A retrospective comparative analysis1
Crescentic glomerulonephritis due to coexistent IgA nephropathy and anti‐glomerular basement membrane disease in a patient with COVID‐19 disease: A case report1
An echocardiography‐derived calcium score as a predictor of major adverse cardiovascular events in peritoneal dialysis patients—A prospective cohort study1
1
Impact of haemodialysis hours on outcomes in older patients1
Management of haemodialysis patients with COVID‐19 in the Omicron BA.4 and BA.5 wave1
Practical considerations for the use of SGLT‐2 inhibitors in the Asia–Pacific countries—An expert consensus statement1
Wnt/β‐catenin signalling mediates cardiac hypertrophy in type 4 cardiorenal syndrome1
Serum chemokine CC‐motif ligand 17 is a predictive marker of severe COVID‐19 in haemodialysis patients: A retrospective observational study1
Acute kidney injury in the tropics1
Everolimus‐associated focal segmental glomerulosclerosis in a liver transplant recipient1
Laparoscopic observations of adhesions between peritoneal dialysis catheters and intraperitoneal organs: A retrospective, observational study1
0.081454038619995